Median CSF λ‐FLC was higher in GFAP‐astrocytopathy (5.5 [3.2; 9.2] mg/L) compared to MS (1.0 [0.1; 1.8] mg/L, p < 0.001, Figure 2C). Here, GFAP is linked to myeloid sarcoma.